| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| azd2066 | metabotropic glutamate receptor 5 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Unipolar Depression[MeSHID:D003866] Gastroesophageal reflux disease[MeSHID:D005764] Neuralgia[MeSHID:D009437] Major Depressive Disorder[MeSHID:D003865] |
6.7 | discontinued in phase 2 | modulator |
| azd2066 | metabotropic glutamate receptor 5 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Unipolar Depression[MeSHID:D003866] Gastroesophageal reflux disease[MeSHID:D005764] Neuralgia[MeSHID:D009437] Major Depressive Disorder[MeSHID:D003865] |
6.7 | discontinued in phase 2 | unknown |
| click here to return to the previous page | ||||||||